Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 26 ... "This is a great accomplishment for the employees of HEI and it opens up an entirely new set of markets for us. We have been building products for the Mil/Aero markets for quite ... Division PO Box 5000, 1495 Steiger Lake Keywords: HEI, Inc., U.S. Food and Drug Administration, FDA This article was prepared by FDA Law Weekly editors ... functional and cost effective product utilizing innovative design solutions and by the application of state-of-the-art materials, processes and manufacturing capabilities. ...
2009 NOV 28 ... completion of ongoing GLP studies, believe we are on track to file an investigational new drug application and initiate a Phase I clinical trial of INX-189 in the first half of 2010." Third ...
2009 NOV 26 -- According to recent research published in the Journal of Aoac International, "A fast, simple reversed-phase HPLC method and two spectrophotometric methods based on principal component regression and partial least squares calibrations were......
2009 NOV 27 ... studies have explored the thermal stability of various materials to provide insight into drug penetration in order to design drug delivery systems, which are not only safe but ... "Thermoanalytical methods have found increasing application in medicine due to the improved sensitivity and usability of the available ...
2009 NOV 23 ... of arsenical and diamidine resistance in Trypanosoma brucei is associated with loss of drug uptake by the P2 purine transporter as a result of alterations in the corresponding T. ... settings, given that eflornithine has a much higher logistical requirement for its application." Kazibwe and colleagues published their study in Plos Neglected Tropical ...
2009 NOV 23 ... Roxane Laboratories, Inc. announced the approval of its Abbreviated New Drug Application (ANDA) for Perindopril Erbumine Tablets, 2mg, 4mg and 8mg by the U.S. Food and Drug ...
2009 NOV 23 ... strong specialty sales force. "In August the FDA accepted for filing our New Drug Application for rifaximin 550mg tablets for the maintenance of remission of hepatic encephalopathy ...
2009 NOV 23 ... journal Naunyn - Schmiedebergs Archives of Pharmacology is: Springer, 233 Spring St., New York, NY 10013, USA. Keywords: City:Sydney, Country:Australia, City:Sydney, ... occurred by 1 h and reached 41% for dura and 24% for skin. Intravenous injection of drug vehicle did not produce significant suppression of responses to stimulation of either ... returned to normal before suppression of the responses to stimulation became manifest. Application of ''inflammatory soup'' to the dura mater produced a pronounced increase in dural ...
2009 NOV 23 ... for the journal Cancer Immunology Immunotherapy is: Springer, 233 Spring St., New York, NY 10013, USA. Keywords: City:Chongqing, Country:People's Republic ... USA. Keywords: City:Chongqing, Country:People's Republic of China, Cancer, Drug Development, Immunology, Immunotherapy, Oncology, Pharmaceuticals, Therapy, Treatment, ... found to elicit a stronger Ran-specific CTL response, indicating a potential anti-tumor application in the future." Li and colleagues published their study in Cancer ...
2009 NOV 24 ... DR system through Shimadzu's worldwide sales channel and the development of fully new applications integrating Shimadzu's state-of-the-art application for digital ... moment.) Keywords: Radiography, Diagnosis, Diagnostics, FDA, U.S. Food and Drug Administration, Edda Technology Inc. This article was prepared by Life ...
2009 NOV 23 ... and Drug Administration (FDA) has acknowledged receipt of Sol-Gel's Investigational New Drug Application (IND) for DER45-EV Gel for the topical treatment of rosacea. This IND allows Sol-Gel to ...
2009 NOV 23 ... Trial Research, Degenerative Disc Disease, FDA, Regulatory Actions, U.S. Food and Drug Administration, SpinalMotion. This article was prepared by Pain & Central ... plans to use the additional funds for completing its Kineflex/C cervical disc PMA application and developing its next-generation artificial discs. It total, the company has enrolled ...
2009 NOV 23 ... information for the American Heart Journal is: Mosby-Elsevier, 360 Park Avenue South, New York, NY 10010-1710, USA. Keywords: Country:Scotland, Life Sciences, ... According to a study from Scotland, "We aimed to analyze trends in drug-eluting stents. (DES) use in four international health care and regulatory settings. ... colleagues, University of Glasgow. The researchers concluded: "The optimum application of DES in clinical practice is unclear and is reflected in the degree of international ...
2009 NOV 23 ... Biotechnology Business, Biotechnology Company, FDA, Symbiontics Inc., U.S. Food and Drug Administration. This article was prepared by Biotech Business Week editors ... compliance under 21 CFR Part 11. Each algorithm is dedicated to a specific method and application, controlling a specified analytical instrument and sampling system, accepting structured ...
2009 NOV 23 ... Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Tap Pharmaceutical's proton pump inhibitor ...
2009 NOV 23 ... that on October 28, 2009, the FDA issued a Complete Response Letter regarding the New Drug Application (NDA) for Intermezzo=AE (zolpidem tartrate sublingual tablet), the lead Transcept ...
2009 NOV 23 ... Dr. Marina Mata, M.D., also a professor of Neurology. "We routinely create new vectors and produce them in the laboratory for animal studies, but in order to have a ... agreements with Diamyd. Keywords: Behavior, Biotechnology, Diabetes, Drug Development, Herpes Simplex, Herpes Simplex Virus, Herpes Virus, Herpesvirus, Neurology, ... crippled herpes simplex viruses can be used to deliver genes to sensory nerves from application in the skin. Fink is directing a phase 1 human trial on the first such ...
2009 NOV 23 ... An oral form of palifosfamide has been developed preclinically to the investigational new drug application stage. Darinaparsin (ZinaparTM or ZIO-101) is a novel organic arsenic being ...
2009 NOV 23 ... An oral form of palifosfamide has been developed preclinically to the investigational new drug application stage. Darinaparsin (ZinaparTM or ZIO-101) is a novel organic arsenic being ...
2009 NOV 23 ... can be used in all CPR training programs or for individual practice at any time. The new app will prepare both professionals and lay rescuers to perform CPR for victims of ... Cardiac Arrest, Cardiology, Defibrillator, FDA, Medical Device, U.S. Food and Drug Administration. This article was prepared by Cardiovascular Week editors ... ZOLL Medical Corporation (NasdaqGS: ZOLL) announced that a PocketCPR® training application (app) for iPhone is now available from the Apple iTunes App Store for $5.99. PocketCPR ...
